NPY Methylated ctDNA is a Promising Biomarker for Treatment Response Monitoring in Metastatic Colorectal Cancer.
Janssens K, Vanhoutte G, Lybaert W, Demey W, Decaestecker J, Hendrickx K, Rezaei Kalantari H, Zwaenepoel K, Pauwels P, Fransen E, Op de Beeck K, Van Camp G, Rolfo C, Peeters M.
Janssens K, et al. Among authors: decaestecker j.
Clin Cancer Res. 2023 May 1;29(9):1741-1750. doi: 10.1158/1078-0432.CCR-22-1500.
Clin Cancer Res. 2023.
PMID: 36716292
Clinical Trial.